Procedural and long-term results of sirolimus-eluting stent in patients at high risk for restenosis

P. Presbitero, D. Zavalloni, M. Scatturin, F. Marsico, P. Pagnotta, G. Boccuzzi

Research output: Contribution to journalArticle

Abstract

Aim. In-stent restenosis still affects 10-50% of long-term outcome after percutaneous coronary intervention (PCI). Large clinical trials have shown that sirolimus-eluting stents (SES) have reduced restenosis rate to 0-9% in lesions at low-moderate risk. The aim of this study was to evaluate long-term clinical and angiographic outcome of SES in a real world population, at very high risk of restenosis. Methods. Ninety lesions at high risk of restenosis (lesion length >20 mm, target vessel diameter

Original languageEnglish
Pages (from-to)189-194
Number of pages6
JournalMinerva Cardioangiologica
Volume52
Issue number3
Publication statusPublished - Jun 2004

Keywords

  • Coronary disease
  • Coronary restenosis
  • Drug delivery systems, methods
  • Sirolimus
  • Stents

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Procedural and long-term results of sirolimus-eluting stent in patients at high risk for restenosis'. Together they form a unique fingerprint.

  • Cite this